We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mutation Identified Leading to Mitochondrial Dysfunction and Heart Failure

By LabMedica International staff writers
Posted on 07 Jun 2011
Print article
A mutation in the gene that encodes for a protein thought to protect cells from stress-induced mitochondrial dysfunction has been linked to the chain of molecular events leading to heart failure.

Mutations in the PTEN-inducible kinase 1 (PINK1) gene cause one form of autosomal recessive early-onset Parkinson's disease. The mutations cause neurons to be more susceptible to reactive oxygen species (ROS) and more likely to undergo apoptosis.

As oxidative stress with associated mitochondrial dysfunction leads to cardiac dysfunction and heart failure (HF), investigators at the Peter Munk Cardiac Center (Toronto, Canada) elected to examine the role of the PINK1 gene in this process.

After observing that PINK1 protein levels were markedly reduced in end-stage human HF and that PINK1 localized exclusively to the mitochondria, the investigators genetically engineered a line of mice to lack the gene for PINK1.

They reported in the May 23, 2011, online edition of the journal Proceedings of the [US] National Academy of Sciences that PINK1 "knockout" mice developed left ventricular dysfunction and evidence of pathological cardiac hypertrophy as early as two months of age. The knockout mice had greater levels of oxidative stress and impaired mitochondrial function. There were also higher degrees of fibrosis, cardiomyocyte apoptosis, and a reciprocal reduction in capillary density.

"Our research suggests that PINK1 is an important switch that sets off a cascade of events affecting heart cell metabolism," said first author Dr. Phyllis Billia, a heart failure specialist at the Peter Munk Cardiac Center. "This could be one of the inciting events in the development of heart failure. We need to learn more about PINK1 and the other proteins it interacts with at the subcellular level, but if we have identified the inciting event that causes the chain of events leading to failure, research and drug development strategies should be focused in this new area of science."

Related Links:
Peter Munk Cardiac Center

New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Laboratory Electric Thermostat
DNP-9025A
New
Chlamydia Test Kit
CHLAMYTOP

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.